Orthofix Medical Inc - Asset Resilience Ratio

Latest as of March 2024: 0.15%

Orthofix Medical Inc (OFIX) has an Asset Resilience Ratio of 0.15% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$1.33 Million
Cash + Short-term Investments

Total Assets

$906.05 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2023)

This chart shows how Orthofix Medical Inc's Asset Resilience Ratio has changed over time. Check OFIX strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Orthofix Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OFIX company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $1.33 Million 0.15%
Total Liquid Assets $1.33 Million 0.15%

Asset Resilience Insights

  • Limited Liquidity: Orthofix Medical Inc maintains only 0.15% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Orthofix Medical Inc Industry Peers by Asset Resilience Ratio

Compare Orthofix Medical Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Bio-Rad Laboratories Inc
NYSE:BIO
Medical Devices 10.80%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Tellgen Corp
SHE:300642
Medical Devices 9.96%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Orthofix Medical Inc (2000–2023)

The table below shows the annual Asset Resilience Ratio data for Orthofix Medical Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -0.50% $-4.65 Million $925.32 Million --
2018-12-31 0.00% $0.00 $466.64 Million --
2017-12-31 0.00% $0.00 $405.35 Million --
2016-12-31 2.87% $10.69 Million $372.10 Million --
2015-12-31 0.00% $0.00 $400.22 Million --
2014-12-31 8.76% $34.42 Million $393.19 Million +3.19pp
2013-12-31 5.56% $23.76 Million $427.10 Million +1.34pp
2012-12-31 4.23% $21.31 Million $504.28 Million -2.55pp
2011-12-31 6.77% $47.10 Million $695.55 Million +2.97pp
2010-12-31 3.80% $22.94 Million $603.99 Million +1.83pp
2009-12-31 1.97% $11.63 Million $590.47 Million +0.01pp
2008-12-31 1.96% $11.00 Million $561.22 Million +0.10pp
2007-12-31 1.86% $16.45 Million $885.66 Million +1.01pp
2006-12-31 0.85% $7.30 Million $862.28 Million -2.06pp
2005-12-31 2.90% $13.76 Million $473.86 Million -0.41pp
2004-12-31 3.32% $14.30 Million $431.10 Million +2.83pp
2000-12-31 0.49% $932.00K $190.43 Million --
pp = percentage points

About Orthofix Medical Inc

NASDAQ:OFIX USA Medical Devices
Market Cap
$476.98 Million
Market Cap Rank
#13249 Global
#3218 in USA
Share Price
$11.80
Change (1 day)
+0.08%
52-Week Range
$8.95 - $16.23
All Time High
$67.71
About

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more